bioAffinity Technologies Files 8-K Report
Ticker: BIAFW · Form: 8-K · Filed: Jul 9, 2024 · CIK: 1712762
Sentiment: neutral
Topics: 8-K, financial-condition, corporate-events
Related Tickers: BIAF
TL;DR
BIAF filed an 8-K on July 9th covering financials and other events. Full details in the filing.
AI Summary
On July 9, 2024, bioAffinity Technologies, Inc. filed an 8-K report detailing significant events. The filing includes information on the company's results of operations and financial condition, as well as other events and financial statements and exhibits. Specific financial figures or operational updates were not detailed in the provided text excerpt.
Why It Matters
This 8-K filing indicates that bioAffinity Technologies, Inc. is providing updates to the SEC regarding its financial condition and other material events. Investors should review the full filing for details.
Risk Assessment
Risk Level: medium — 8-K filings can contain material information, but without specific details on the events or financial condition, the risk level is moderate.
Key Players & Entities
- bioAffinity Technologies, Inc. (company) — Registrant
- July 9, 2024 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 001-41463 (commission_file_number) — SEC File Number
- 46-5211056 (tax_id) — I.R.S. Employer Identification Number
- 22211 W Interstate 10 Suite 1206 San Antonio, Texas 78257 (address) — Business Address
- 210-698 (phone_number) — Business Phone
FAQ
What specific "Results of Operations and Financial Condition" are being reported by bioAffinity Technologies, Inc. in this 8-K?
The provided excerpt of the 8-K filing does not contain specific details regarding the results of operations or financial condition, only that these items are covered in the report.
What are the 'Other Events' mentioned in the 8-K filing for bioAffinity Technologies, Inc. on July 9, 2024?
The excerpt states that 'Other Events' are part of the 8-K filing, but does not specify what those events are.
What is the significance of the filing date of July 9, 2024, for bioAffinity Technologies, Inc.?
July 9, 2024, is the date of the report and the earliest event reported, indicating that the company is disclosing material information as of this date.
Where is bioAffinity Technologies, Inc. incorporated, and what is its IRS Employer Identification Number?
bioAffinity Technologies, Inc. is incorporated in Delaware and its IRS Employer Identification Number is 46-5211056.
What is the business address and phone number for bioAffinity Technologies, Inc. as listed in the filing?
The business address is 22211 W Interstate 10 Suite 1206 San Antonio, Texas 78257, and the phone number is (210) 698.
Filing Stats: 646 words · 3 min read · ~2 pages · Grade level 10.1 · Accepted 2024-07-09 16:30:12
Key Financial Figures
- $0.007 — ch registered Common Stock, par value $0.007 per share BIAF The Nasdaq Stock Mar
Filing Documents
- form8-k.htm (8-K) — 42KB
- ex99-1.htm (EX-99.1) — 20KB
- ex99-1_001.jpg (GRAPHIC) — 6KB
- ex99-1_002.jpg (GRAPHIC) — 3KB
- 0001493152-24-026639.txt ( ) — 295KB
- biaf-20240709.xsd (EX-101.SCH) — 4KB
- biaf-20240709_def.xml (EX-101.DEF) — 26KB
- biaf-20240709_lab.xml (EX-101.LAB) — 36KB
- biaf-20240709_pre.xml (EX-101.PRE) — 25KB
- form8-k_htm.xml (XML) — 6KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. bioAffinity Technologies, Inc. By: /s/ Maria Zannes Maria Zannes President and Chief Executive Officer Dated: July 9, 2024